UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 865

Sortiert nach

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

The New England journal of medicine, 2021-01, Vol.384 (1), p.11-19

2021

Volltextzugriff (PDF)

Chronic steroid‐response pancytopenia and increased bone density due to thromboxane synthase deficiency

Pediatric blood & cancer, 2018-01, Vol.65 (1), p.n/a

2018

Volltextzugriff (PDF)

From Boring to Bravo! Using Learning Science to Create Memorable Presentations

American Society of Clinical Oncology educational book, 2023-05, Vol.43 (43), p.e389392-e389392

2023

Volltextzugriff (PDF)

Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia

Cancer Immunotherapies, 2022, Vol.183, p.225-254

2022

Volltextzugriff (PDF)

Teaching the Physical Examination: A Longitudinal Strategy for Tomorrow’s Physicians

Academic medicine, 2014-03, Vol.89 (3), p.373-375

2014

Volltextzugriff (PDF)

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.121-128

2021

Volltextzugriff (PDF)

In Reply to Gowda et al and to Yudkowsky

Academic medicine, 2014-06, Vol.89 (6), p.835-835

2014

Volltextzugriff (PDF)

Does Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein Synthesis?

Clinical infectious diseases, 2005-06, Vol.40 (12), p.e113-e116

2005

Volltextzugriff (PDF)

P042 Impact of minor HLA allelic mismatches on outcomes of hematopoietic cell transplants

Human immunology, 2016-09, Vol.77, p.70-70

2016

Volltextzugriff (PDF)

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

American journal of hematology, 2015-02, Vol.90 (2), p.97-99

2015

Volltextzugriff (PDF)

Multimodality, online oncology learning resources: Meeting residents where they are—A pilot to create a new oncology curriculum

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11035-11035

2023

Volltextzugriff (PDF)

Chronic Pancytopenia and Increased Bone Density Due to TBXAS1 Deficiency

Blood, 2016-12, Vol.128 (22), p.1503-1503

2016

Volltextzugriff (PDF)

Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

Biology of blood and marrow transplantation, 2018-07, Vol.24 (7), p.1497-1504

2018

Volltextzugriff (PDF)

Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease

The American journal of dermatopathology, 2007-02, Vol.29 (1), p.1-6

2007

Volltextzugriff (PDF)

221 - Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S172-S173

2023

Volltextzugriff (PDF)

Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S172-S173

2023

Volltextzugriff (PDF)

Reduced-intensity allogeneic hematopoietic cell transplantation: Graft versus tumor effects with decreased toxicity

Pediatric transplantation, 2003-06, Vol.7 (3), p.168-178

2003

Volltextzugriff (PDF)

Higher CD34+ Cell Doses Reduce the Cost of Tandem Autologous Stem Cell Transplants for Relapsed or Refractory Germ Cell Tumors

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S64-S64

2016

Volltextzugriff (PDF)

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Blood, 2014-12, Vol.124 (21), p.5874-5874

2014

Volltextzugriff (PDF)

Cyclophosphamide/fludarabine-based nonmyeloablative matched related/unrelated allotransplant for myelodysplasia

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7042-7042

2014

Volltextzugriff (PDF)

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2011-07, Vol.17 (7), p.987-994

2011

Volltextzugriff (PDF)

The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors

Blood, 2010-11, Vol.116 (21), p.2345-2345

2010

Volltextzugriff (PDF)

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Blood, 2009-11, Vol.114 (22), p.3402-3402

2009

Volltextzugriff (PDF)

T Regulatory Cells in Graft-Versus-Host Disease of the Skin

Blood, 2008-11, Vol.112 (11), p.4354-4354

2008

Volltextzugriff (PDF)

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Blood, 2009-11, Vol.114 (22), p.198-198

2009

Volltextzugriff (PDF)

1 – 25 von 865

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(801)
Mit Volltextzugriff
(779)

Publikationsform

Sprache

Englisch
(861)
Japanisch
(135)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

Chronic steroid‐response pancytopenia and increased bone density due to thromboxane synthase deficiency

From Boring to Bravo! Using Learning Science to Create Memorable Presentations

Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia

Teaching the Physical Examination: A Longitudinal Strategy for Tomorrow’s Physicians

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

In Reply to Gowda et al and to Yudkowsky

Does Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein Synthesis?

P042 Impact of minor HLA allelic mismatches on outcomes of hematopoietic cell transplants

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Multimodality, online oncology learning resources: Meeting residents where they are—A pilot to create a new oncology curriculum

Chronic Pancytopenia and Increased Bone Density Due to TBXAS1 Deficiency

Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease

221 - Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant

Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant

Reduced-intensity allogeneic hematopoietic cell transplantation: Graft versus tumor effects with decreased toxicity

Higher CD34+ Cell Doses Reduce the Cost of Tandem Autologous Stem Cell Transplants for Relapsed or Refractory Germ Cell Tumors

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Cyclophosphamide/fludarabine-based nonmyeloablative matched related/unrelated allotransplant for myelodysplasia

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

T Regulatory Cells in Graft-Versus-Host Disease of the Skin

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Suchergebnisse filtern